Epigenetic modification mechanisms involved in keloid: current status and prospect
- PMID: 33243301
- PMCID: PMC7690154
- DOI: 10.1186/s13148-020-00981-8
Epigenetic modification mechanisms involved in keloid: current status and prospect
Abstract
Keloid, a common dermal fibroproliferative disorder, is benign skin tumors characterized by the aggressive fibroblasts proliferation and excessive accumulation of extracellular matrix. However, common therapeutic approaches of keloid have limited effectiveness, emphasizing the momentousness of developing innovative mechanisms and therapeutic strategies. Epigenetics, representing the potential link of complex interactions between genetics and external risk factors, is currently under intense scrutiny. Accumulating evidence has demonstrated that multiple diverse and reversible epigenetic modifications, represented by DNA methylation, histone modification, and non-coding RNAs (ncRNAs), play a critical role in gene regulation and downstream fibroblastic function in keloid. Importantly, abnormal epigenetic modification manipulates multiple behaviors of keloid-derived fibroblasts, which served as the main cellular components in keloid skin tissue, including proliferation, migration, apoptosis, and differentiation. Here, we have reviewed and summarized the present available clinical and experimental studies to deeply investigate the expression profiles and clarify the mechanisms of epigenetic modification in the progression of keloid, mainly including DNA methylation, histone modification, and ncRNAs (miRNA, lncRNA, and circRNA). Besides, we also provide the challenges and future perspectives associated with epigenetics modification in keloid. Deciphering the complicated epigenetic modification in keloid is hopeful to bring novel insights into the pathogenesis etiology and diagnostic/therapeutic targets in keloid, laying a foundation for optimal keloid ending.
Keywords: DNA methylation; Epigenetic modification; Histone modification; Keloid; ncRNAs.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
From genetics to epigenetics: new insights into keloid scarring.Cell Prolif. 2017 Apr;50(2):e12326. doi: 10.1111/cpr.12326. Epub 2017 Jan 5. Cell Prolif. 2017. PMID: 28054407 Free PMC article. Review.
-
The epigenetics of keloids.Exp Dermatol. 2021 Aug;30(8):1099-1114. doi: 10.1111/exd.14414. Epub 2021 Jun 30. Exp Dermatol. 2021. PMID: 34152651 Review.
-
Genetics and Epigenetics of Keloids.Adv Wound Care (New Rochelle). 2022 Apr;11(4):192-201. doi: 10.1089/wound.2021.0094. Epub 2021 Dec 27. Adv Wound Care (New Rochelle). 2022. PMID: 34498914
-
Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis.Expert Opin Ther Targets. 2015 May;19(5):707-16. doi: 10.1517/14728222.2014.1001740. Epub 2015 Feb 4. Expert Opin Ther Targets. 2015. PMID: 25652534 Review.
-
MiR-152-3p regulates cell proliferation, invasion and extracellular matrix expression through by targeting FOXF1 in keloid fibroblasts.Life Sci. 2019 Oct 1;234:116779. doi: 10.1016/j.lfs.2019.116779. Epub 2019 Aug 17. Life Sci. 2019. PMID: 31430452
Cited by
-
Future Directions About Keloid Scars Based on Pathogenesis and Therapies.Clin Cosmet Investig Dermatol. 2024 Oct 25;17:2391-2408. doi: 10.2147/CCID.S470650. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 39474263 Free PMC article. Review.
-
Circ_0057452 functions as a ceRNA in hypertrophic scar fibroblast proliferation and VEGF expression by regulating TGF-β2 expression and adsorbing miR-145-5p.Am J Transl Res. 2021 Jun 15;13(6):6200-6210. eCollection 2021. Am J Transl Res. 2021. PMID: 34306359 Free PMC article.
-
EIF4A3 Enhances the Proliferation and Cell Cycle Progression of Keloid Fibroblasts by Inducing the hsa_circ_0002198 Expression.Clin Cosmet Investig Dermatol. 2024 Dec 30;17:3045-3058. doi: 10.2147/CCID.S475940. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 39759393 Free PMC article.
-
Targeting the nuclear long noncoding transcript LSP1P5 abrogates extracellular matrix deposition by trans-upregulating CEBPA in keloids.Mol Ther. 2024 Jun 5;32(6):1984-1999. doi: 10.1016/j.ymthe.2024.03.031. Epub 2024 Mar 28. Mol Ther. 2024. PMID: 38553852 Free PMC article.
-
MicroRNA-182-5p Inhibits Hypertrophic Scar Formation by Inhibiting the Proliferation and Migration of Fibroblasts via SMAD4 Pathway.Clin Cosmet Investig Dermatol. 2023 Mar 8;16:565-580. doi: 10.2147/CCID.S397808. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36919011 Free PMC article.
References
-
- Saveria Fioretto B, Rosa I, Romano E, Wang Y, Guiducci S, Zhang G, Manetti M, Matucci-Cerinic M. The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Ther Adv Musculoskelet Dis. 2020;12:1759720X20918456. doi: 10.1177/1759720X20918456. - DOI - PMC - PubMed
-
- Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015;30(9):1033–1057. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources